the aid library

LIST OPTIONS

Filter

786

Sort by:

Direction:

Download (2053)

View PDF (1858)

Birth defects surveillance: a manual for programme managers

World Health Organization (2014)

Download (757)

View PDF (1272)

Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik

Indonesian Rheumatology Association (2011) C1

Diagnosis and Management of Systemic Lupus Erythematosus

Download (8191)

View PDF (661)

Guidelines Infeksi Saluran Kemih

Indonesian Urological Association (2007) C1

Guidelines for Therapy and Management of Urinary Tract Infection

Download (1648)

View PDF (1093)

Manual de manejo de enfermedades crónicas no transmisibles
recommended

Ministerio de Salud Pública y Bienestar Social Paraguay: Organización Panamericana de la Salud, et al. (2015) C_WHO

Desde Atencion primaria de salud

Download (838)

View PDF (1328)

Peraturan Menteri Kesehatan Republik Indonesia Nomor 87 Tahun 2014 tentang Pedoman Pengobatan Antiretroviral

Ministry of Health Republic of Indonesia (2014) C1

Regulation of the Minister of Health of the Republic of Indonesia on Guidelines for Antiretroviral Treatment

Download (181)

View PDF (261)

Alcohol and Public Health in the Americas

Pan American Health Organization (PAHO) (2007) C_WHO

Making the Case for Alcohol as a Public Health Threat in the Region. The purpose of this document is to explain the need for making alcohol a top public health priority in the region and the need for national and regional action. Current evidence-based research shows that alcohol consumption and dri... more

Download (526)

View PDF (828)

Guidelines for Eye Care

Ministry of Health Uganda (2016) C1

Download (390)

View PDF (622)

Indonesia: Buku petunjuk penggunaan media kie versi pekerja dan mahasiswa

Kementerian Koordinator Bidang Kesejahteraan Rakyat Republik Indonesia, Kementerian Kesehatan Republik Indonesia, et al. (2012) C1

Download (1647)

View PDF (3227)

Peraturan Menteri Kesehatan Republik Indonesia Nomor 5 Tahun 2014 Tentang Panduan Praktik Klinis Bagi Dokter Di Fasilitas Pelayanan Kesehatan Primer

Menteri Kesehatan Republik Indonesia (2014) C1

Regulation of the Minister of Health of the Republic of Indonesia Number 5 Year 2014 about the Clinical Practice Guide for Physicians at Primary Health Care Facilities

Download (1127)

View PDF (1864)

Support Services for Survivors of Ebola Virus Disease — Sierra Leone, 2014

Seung Hee Lee-Kwan, et al. (2014)

MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206

Download (643)

View PDF (622)

Service Standards and Service Delivery Standards for the Health Sector

Republic of Uganda, Ministry of Health (2016) C1

The Ministry of Health has developed the first version of the Service Standards and Service Delivery Standards for the health sector in Uganda. The main objective is to provide a common understanding of what is expected by the public, service users and service providers in ensuring provision of cons... more

Download (401)

View PDF (304)

National Guidelines on the Management of Moderate Acute Malnutrition for Children under Five Years

World Food Programme (WFP) (2016) C1

Manual of Operations First Edition 2016

Download (93)

View PDF (121)

Key Considerations: Emerging evidence on shielding vulnerable groups during COVID-19

Schmidt-Sane M. SSHAP (2020) CC

Shielding is a term used to describe the protection of individuals at high risk of severe COVID-19 illness by separating them from the general population.

Download (120)

View PDF (98)

Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años

Ministerio de Salud y Protección Social, Colombia (2016) C2

Sistema General de Seguridad Social en Salud – Colombia Guía No. GPC-2015-51

Download (156)

View PDF (517)

Lignes directrices provisoires de l’OMS pour le traitement de la trypanosomiase humaine africaine à T. b. gambiense

World Health Organization WHO (2019) C_WHO

Les progrès remarquables réalisés dans la lutte contre la forme à T. b. gambiense reposent sur le dépistage et le traitement curatif, une stratégie qui interrompt la transmission en réduisant le réservoir de parasites chez l’être humain. Parfois, cette approche a été combinée avec des... more

Download (96)

View PDF (271)

Full prescribing information Fexinidazole tablets, for oral use

Drugs for Neglected Diseases initiative DNDi (2021) C1

Full Perscribing information on Fexinidazole Tablet for oral use INDICATIONS AND USAGE Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (23)

View PDF (22)

Epidemiology of Peripheral Artery Disease and Polyvascular Disease

Aday A.W.; Matsushita, K. Circulation Research (2021) CC

Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ... more

Download (15)

View PDF (19)

The BACPR Standards and Core Components for Cardiovascular Disease Prevention and Rehabilitation 2017

British Association for Cardiovascular Prevention and Rehabilitation (2017) CC

This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards... more

Download (24)

View PDF (21)

Kenya Asthma Management Guideline

Ministry of Health (2021) CC

Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid... more

Manual de manejo de enfermedades crónicas no transmisibles recommended

Manual de manejo de enfermedades crónicas no transmisibles
recommended